Zhimiao Zou
Key Laboratory Of Organ Transplantation, NHC Key Laboratory Of Organ Transplantation, Key Laboratory Of Organ Transplantation
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction: TJ-M2010-5 Attenuates Severe Myocardial Ischemia/Reperfusion Injury in Heart Transplantation by Inhibiting MyD88 Homodimerization In Vivo.
Journal: Journal of cardiovascular translational research
Published: April 16, 2024
Treatment of a MyD88 inhibitor alleviates rejection and inflammation in xenotransplantation by inhibiting dendritic cells activation and trained immunity in macrophages.
Journal: International immunopharmacology
Published: December 09, 2023
The role of pyroptosis in hepatocellular carcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: February 20, 2023
TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway.
Journal: Frontiers in pharmacology
Published: October 26, 2022
TJ-M2010-5 Attenuates Severe Myocardial Ischemia/Reperfusion Injury in Heart Transplantation by Inhibiting MyD88 Homodimerization In Vivo.
Journal: Journal of cardiovascular translational research
Published: October 29, 2021
TJ-M2010-5, A self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-κB pathway.
Journal: Chemico-biological interactions
Published: October 28, 2021
TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.
Journal: International immunopharmacology
Published: April 09, 2020
Inhibition of MyD88 by a novel inhibitor reverses two-thirds of the infarct area in myocardial ischemia and reperfusion injury.
Journal: American journal of translational research
Published: January 03, 2020
Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice.
Journal: International immunopharmacology
Published: September 08, 2018
Human MiR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis.
Journal: Clinical and experimental nephrology
Published: August 16, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026